Series C Therapeutics Companies

Accent Therapeutics is a biopharmaceutical company.

Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.

Beacon Therapeutics is a biotechnology company that develops treatments to preserve and restore vision for rare and prevalent eye diseases.

Ukko is a biotechnology company focused on developing immunotherapies for the treatment of allergies and other immune-mediated diseases.

Genomics plc aiming to lead the genomic transformation of healthcare.

Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs.

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.

Apollo Therapeutics is a portfolio biopharmaceutical company focused on translating medical research into medicines.

SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.

NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.

Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury.

HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.

Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.

Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.

Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.